Target intelligence / Profile preview

Escherichia coli surface-expressed antigens

Molecular classification
Other (as a group: includes Polysaccharide antigen, Surface protein, Structural protein, Flagellin), Each individual antigen (e.g., O-antigen: Polysaccharide antigen; H-antigen: Flagellar protein; K-antigen: Capsular polysaccharide; Ag43: Autotransporter adhesin)
01

Overview

Escherichia coli surface-expressed antigens refer to a heterogeneous set of molecular structures located on the external surface of the E. coli cell, including the lipopolysaccharide (LPS) O-antigen, capsular K-antigen, flagellar H-antigen, and a variety of adhesins like Antigen 43. These antigens play central roles in immune evasion, biofilm formation, and virulence, and their immense structural diversity underpins serotyping systems used in diagnostics and epidemiology[2][5][6][7]. Because the term represents a group of targets rather than a single molecular entity, structured information needs to be obtained for each antigen individually for precise scientific or therapeutic work. Key notes: - The entity is too broad and not a canonical molecular target name; it refers to a collection of targets, each meriting its own entry. - If a structured database is sought, O-antigen (LPS), K-antigen (Capsule), H-antigen (Flagellin), and one or more specific surface proteins (e.g., Antigen 43) should each be considered individual targets[2][4][5][7]. - "Escherichia coli surface-expressed antigens" is extensively used in the context of serotyping and vaccine/antibody development, but not a standardized singular target.

Other names
O-antigenK-antigenH-antigenAntigen 43 (Ag43)surface antigenssurface adhesin
02

Mechanism of action

Immune recognition and neutralization (polyclonal or monoclonal antibodies bind to surface antigens and facilitate opsonization and clearance); Prevention of adherence/biofilm formation by targeting adhesins (e.g., Ag43 inhibition disrupts aggregation)

03

Biological functions

Immune evasionBiofilm formationHost-pathogen interactionVirulence/PathogenesisCellular adhesion
04

Disease associations

InfectionDiarrheal diseaseUrinary tract infectionSepsisMeningitisOther (varies depending on the antigen)
05

Safety considerations

Antigenic diversity complicates vaccine and antibody therapy developmentPossibility of cross-reactivity with human tissues or other bacterial species
06

Interacting drugs

Monoclonal antibodies to specific O-, K-, or H-antigens (experimental/diagnostic)

1 more in the full profile.

07

Biomarkers

O-antigen serogroups (e.g., for epidemiology/typing)K-antigen typesH-antigen types

Beyond the preview

Go deeper on Escherichia coli surface-expressed antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli surface-expressed antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call